ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Earnings Results
ResMed share price crashes 10% on FY23 earnings miss
Earnings Results
Experts forecast the ASX 200 winners and losers this earnings season
Share Market News
5 things to watch on the ASX 200 on Friday
Share Market News
Here are the top 10 ASX 200 shares today
Broker Notes
Top brokers name 3 ASX shares to buy today
Broker Notes
'Attractive price': Rare buying opportunity for this quality ASX 200 share just opened
Cheap Shares
'A cracking market': 2 'compelling' ASX 200 shares Airlie just bought
Blue Chip Shares
Bolster your portfolio with these super strong ASX 200 blue-chip shares
Growth Shares
These ASX growth shares are top buys: broker
Share Gainers
Here are the top 10 ASX 200 shares today
Share Market News
Guess which ASX 200 CEOs are the highest paid
How to invest
Does your ASX investment strategy match your risk tolerance?
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
